RecruitingPhase not listedNCT06297291
Global Paradise System US Post Approval Study
Sponsor: ReCor Medical, Inc.
Austin, TX · Dallas, TX · Kingwood, TX · +43 more sites
Hypertension clinical trials in Austin, TX
7 recruiting hypertension studies with a site in Austin, TX.
RecruitingPhase 3NCT07181109
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
Sponsor: Alnylam Pharmaceuticals
Allen, TX · Amarillo, TX · +270 more sites
RecruitingPhase 3NCT06742723
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
Sponsor: AstraZeneca
Arlington, TX · Austin, TX · +130 more sites
RecruitingNot applicableNCT04553523
Hydrus® Microstent New Enrollment Post-Approval Study
Sponsor: Alcon Research
Austin, TX · Dallas, TX · El Paso, TX · +19 more sites
RecruitingPhase not listedNCT04278404
Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
Sponsor: Duke University
Austin, TX · Dallas, TX · Houston, TX · +47 more sites
RecruitingPhase 1 / Phase 2NCT06649110
A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B)
Sponsor: Novartis Pharmaceuticals
Austin, TX · Dallas, TX · +17 more sites
RecruitingPhase 3NCT05401357
Bioequivalence Study With Clinical Endpoint Comparing Bimatoprost Ophthalmic Solution 0.01% and LUMIGAN® in the Treatment of Chronic Open-Angle Glaucoma or Ocular Hypertension in Both Eyes.
Sponsor: Amneal Pharmaceuticals, LLC
Austin, TX · Houston, TX · +7 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.